IRIS

VIGNERI, PAOLO

VIGNERI, PAOLO  

MEDICINA CLINICA E SPERIMENTALE  

Risultati 1 - 20 di 210 (tempo di esecuzione: 0.032 secondi).
Titolo Data di pubblicazione Autore(i) File
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line 1-gen-2017 Castagnetti, F; DI RAIMONDO, Francesco; De Vivo, A; Spitaleri, A; Gugliotta, G; Fabbiano, F; Capodanno, I; Mannina, D; Salvucci, M; Antolino, A; Marasca, R; Musso, M; Crugnola, M; Impera, S; Trabacchi, E; Musolino, C; Cavazzini, F; Mineo, G; Tosi, P; Tomaselli, C; Rizzo, M; Siragusa, S; Fogli, M; Ragionieri, R; Zironi, A; Soverini, S; Martinelli, G; Cavo, M; Vigneri, Paolo; Stagno, F; Rosti, G; Baccarani, M.
Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment 1-gen-2019 Manzella, L.; Massimino, M.; Stella, S.; Tirro, E.; Pennisi, M. S.; Martorana, F.; Motta, G.; Vitale, S. R.; Puma, A.; Romano, C.; Di Gregorio, S.; Russo, M.; Malandrino, P.; Vigneri, P.
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery 1-gen-2021 Di Franco, S.; Bianca, P.; Sardina, D. S.; Turdo, A.; Gaggianesi, M.; Veschi, V.; Nicotra, A.; Mangiapane, L. R.; Lo Iacono, M.; Pillitteri, I.; van Hooff, S.; Martorana, F.; Motta, G.; Gulotta, E.; Lentini, V. L.; Martorana, E.; Fiori, M. E.; Vieni, S.; Bongiorno, M. R.; Giannone, G.; Giuffrida, D.; Memeo, L.; Colarossi, L.; Mare, M.; Vigneri, P.; Todaro, M.; De Maria, R.; Medema, J. P.; Stassi, G.
Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma 1-gen-1996 Bongarzone, I; Fugazzola, L; Vigneri, Paolo; Mariani, L; Mondellini, P; Pacini, F; Basolo, F; Pinchera, A; Pilotti, S; Pierotti, Ma
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer? 1-gen-2021 Martorana, F.; Motta, G.; Pavone, G.; Motta, L.; Stella, S.; Vitale, S. R.; Manzella, L.; Vigneri, P.
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.Cancer Res 1-gen-2006 Tirro, E; Consoli, Ml; Massimino, M; Manzella, L; Frasca, F; Sciacca, L; Vicari, L; Stassi, G; Messina, L.; Messina, A; Vigneri, P
AN INSERTION IN THE BCR-ABL KINASE DOMAIN CONTRIBUTES TO IMATINIB MESYLATE RESISTANCE 1-gen-2008 Vigneri, Paolo; Stagno, F.; Massimino, M.; Berretta, S.; Stella, S.; DEL FABRO, V.; Messina, A.; DI RAIMONDO, Francesco
Anaplastic thyroid cancer in sicily: The role of environmental characteristics. 1-gen-2017 Tavarelli, Martina; Malandrino, Pasqualino; Vigneri, Paolo; Richiusa, Pierina; Maniglia, Adele; Violi, Maria A.; Sapuppo, Giulia; Vella, Veronica; Dardanoni, Gabriella; Vigneri, Riccardo; Pellegriti, Gabriella; Vella, Veronica
Basal insulin and cardiovascular and other outcomes 1-gen-2012 Vigneri, R; Vigneri, Paolo; Frittitta, Lucia
BCR-ABL modifies the expression and function of the IRF-5 transcription factor 1-gen-2007 Vigneri, Paolo
BCR-ABL nuclear entrapment by the combination of imatinib mesylate and leptomycin B kilss CML cells: ex vivo study on 35 patients 1-gen-2004 Vigneri, Paolo; Aloisi, A; Digregorio, S; Stagno, F; Guglielmo, P; Sormani, Mp; Bruzzi, P; Giustolisi, R; Messina, A.
BCR-ABL nuclear entrapment kills human CML cells: ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin B 1-gen-2006 Aloisi, A; DI GREGORIO, S; Stagno, F; Guglielmo, P; Mannino, F; Sormani, Mp; Bruzzi, P; GAMBACORTI PASSERINI, C; Saglio, G; Venuta, S; Giustolisi, R; Messina, A; Vigneri, Paolo
BCR-ABL nuclear traslocation transforms the oncoprotein in an inducer of apoptosis: a new potential therapeutic strategy 1-gen-2004 Aloisi, A; DI GREGORIO, S; Stagno, F; Venuta, S; Messina, A.; Vigneri, Paolo
BCR-ABL residues interacting with ponatinib are critical to preserve the tumorigenic potential of the oncoprotein 1-gen-2014 Buffa, P; Romano, C; Pandini, A; Massimino, M; Tirrò, E; DI RAIMONDO, Francesco; Manzella, Livia; Fraternali, F; Vigneri, Paolo
BCR-ABL tyrosine kinase activity modulates Survivin expression in CML cells 1-gen-2005 S., Stella; E., Tirro'; E., Conte; Manzella, Livia; E., Palio; Vigneri, Paolo; Messina, A.
BCR-ABL tyrosine kinase activity modulates survivin expression via PI3K/AKT 1-gen-2005 Manzella, Livia; Conte, E; Tirro', E; Stella, S; Palio, E; Vigneri, Paolo; Messina, A.
BCR-Abl tyrosine kinase activity modulates the expression of Interferon Regulatory Factor-5 in CML cells 1-gen-2005 Manzella, Livia; Massimino, M.; Fallica, M.; Consoli, M. L.; Vigneri, Paolo; Messina, A.
BCR-ABL tyrosine kinase activity modulates the phosphorylation and the localization of Interferon Regulatory Factor 5 (IRF-5)in Chronic Myeloid Leukemia cells 1-gen-2008 Manzella, Livia; Massimino, M; Fallica, M; Consoli, Ml; Aloisi, A; Messina, A; Vigneri, Paolo
BCR-ABL TYROSINE KINASE ACTIVITY MODULATES THE PHOSPHORYLATION, LOCALIZATION AND FUNCTION OF INTERFERON REGULATORY FACTOR 5 (IRF-5) IN CHRONIC MYELOID LEUKEMIA CELLS 1-gen-2010 Manzella, Livia; Massimino, M; Consoli, Ml; Fidilio, A; Buffa, P; Fallica, M; Messina, A; Vigneri, Paolo
BCR-ABL TYROSINE KINASE ACTIVITY MODULATES THE PHOSPHORYLATION, LOCALIZATION AND BIOLOGICAL FUNCTION OF INTERFERON REGULATORY FACTOR 5 IN CHRONIC MYELOID LEUKEMIA CELLS 1-gen-2010 Manzella, Livia; Massimino, M; Consoli, M; Fidilio, A; Buffa, P; Fallica, M; Messina, A; Vigneri, Paolo